See more : AMPD Ventures Inc. (AMPDF) Income Statement Analysis – Financial Results
Complete financial analysis of NDT Pharmaceuticals Inc. (NDTP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NDT Pharmaceuticals Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Rainbow Foundations Limited (RAINBOWF.BO) Income Statement Analysis – Financial Results
- Apollo Micro Systems Limited (APOLLO.BO) Income Statement Analysis – Financial Results
- NewHold Investment Corp. II (NHICU) Income Statement Analysis – Financial Results
- PharmaEngine, Inc. (4162.TWO) Income Statement Analysis – Financial Results
- Triboo S.p.A. (TB.MI) Income Statement Analysis – Financial Results
NDT Pharmaceuticals Inc. (NDTP)
About NDT Pharmaceuticals Inc.
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2010 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.52K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.23K | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.52K | 0.00 | -14.23K | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 25.17K | 0.00 | 0.00 | 0.00 | 0.00 | 1.24K | 1.93K | 87.33K | 260.67K | 253.76K | 61.43K | 37.53K | 5.77K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 25.17K | 0.00 | 0.00 | 0.00 | 0.00 | 1.24K | 1.93K | 87.33K | 260.67K | 253.76K | 61.43K | 37.53K | 5.77K |
| Cost & Expenses | 25.17K | 0.00 | 0.00 | 0.00 | 0.00 | 1.24K | 1.93K | 87.33K | 260.67K | 253.76K | 61.43K | 51.76K | 5.77K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 27.33K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.50K | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00M | 0.00 | 0.00 |
| EBITDA | -79.03K | 0.00 | 0.00 | 0.00 | 0.00 | -1.24K | -1.93K | -87.33K | -260.67K | -246.24K | -59.93K | -51.76K | -5.77K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,276.65% | 0.00% | 0.00% | 0.00% |
| Operating Income | -25.17K | 0.00 | 0.00 | 0.00 | 0.00 | -1.24K | -1.93K | -87.33K | -260.67K | -246.24K | -1.06M | -51.76K | -5.77K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,276.65% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -53.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | -4.00 | 0.00 | -1.00M | 0.00 | 0.00 |
| Income Before Tax | -79.03K | 0.00 | 0.00 | 0.00 | 0.00 | -1.24K | -1.93K | -87.33K | -260.67K | -246.24K | -2.06M | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,276.65% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -167.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.03M | 51.76K | 5.77K |
| Net Income | -79.03K | 0.00 | 0.00 | 0.00 | 0.00 | -1.24K | -1.93K | -87.33K | -260.67K | -246.24K | -1.04M | -51.76K | -5.77K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,276.65% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.29 | -0.86 | -0.71 | -24.67 | -2.00 | -0.43 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.29 | -0.86 | -0.71 | -24.67 | -2.00 | -0.43 |
| Weighted Avg Shares Out | 160.00M | 0.00 | 0.00 | 0.00 | 0.00 | 302.45K | 302.45K | 302.45K | 302.45K | 347.45K | 42.03K | 25.88K | 13.47K |
| Weighted Avg Shares Out (Dil) | 160.00M | 0.00 | 0.00 | 0.00 | 0.00 | 302.45K | 302.45K | 302.45K | 302.45K | 347.45K | 42.03K | 25.88K | 13.47K |
No news found for: NDTP
Source: https://incomestatements.info
Category: Stock Reports